Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Trius Therapeutics Inc | d10k.htm |
| EX-32.1 - CERTIFICATION OF CEO - Trius Therapeutics Inc | dex321.htm |
| EX-32.2 - CERTIFICATION OF CFO - Trius Therapeutics Inc | dex322.htm |
| EX-31.1 - CERTIFICATION OF CEO - Trius Therapeutics Inc | dex311.htm |
| EX-31.2 - CERTIFICATION OF CFO - Trius Therapeutics Inc | dex312.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-168494) pertaining to the Amended and Restated 2006 Equity Incentive Plan, 2010 Equity Incentive Plan, 2010 Non-Employee Directors’ Stock Option Plan, and 2010 Employee Stock Purchase Plan of Trius Therapeutics, Inc. of our report dated March 24, 2011, with respect to the financial statements of Trius Therapeutics, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ Ernst & Young LLP
San Diego, California
March 24, 2011